This compound is an active pharmaceutical ingredient (API) featuring a complex polycyclic structure with amide, amine, heterocycle, and nitrile functional groups. It is identified by the patent reference US9873709, Example 2-285 and is associated with pharmaceutical manufacturing or research applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing US9873709, Example 2-285?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Irinotecan hydrochloride trihydrate
pharmaceutical raw material
Cyclopropanecarboxamide, N-[[[(1R,2R)-2-[[4,4-difluoro-4-(3-hydroxy-2-quinoxalinyl)-2-buten-1-yl]oxy]cyclopentyl]oxy]carbonyl]-3-methyl-L-valyl-(4R)-4-hydroxy-L-prolyl-1-amino-2-(difluoromethyl)-N-[(1-methylcyclopropyl)sulfonyl]-, cyclic (1→2)-ether,
pharmaceutical raw material
(RS)-nefopam
pharmaceutical raw material
Sulfuric acid--{(4S)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]cyclopent-1-en-1-yl}methanol (1/2)
pharmaceutical raw material
4-[[amino-[[3-[1-(4-cyanocyclohexanecarbonyl)-3,6-dihydro-2H-pyridin-4-yl]-3H-pyridin-2-ylidene]amino]methylidene]amino]-N-methyl-N-(1-methylpiperidin-4-yl)benzamide
BQAPTTAMWGDHOR-UHFFFAOYSA-N
CN1CCC(CC1)N(C)C(=O)C2=CC=C(C=C2)N=C(N)N=C3C(C=CC=N3)C4=CCN(CC4)C(=O)C5CCC(CC5)C#N
Sourcing US9873709, Example 2-285?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.